To our knowledge, this is the first study to evaluate the prognostic value of RAR in pediatric CAP. Our findings demonstrate a strong association between RAR levels and adverse clinical outcomes. Given its simplicity, cost, and availability, RAR may serve as a valuable biomarker to support risk stratification and prognostication in children with CAP.
Zühal Örnek (Thu,) studied this question.